With increasing information overload and packed work schedules, staying up-to-date on the newest oncologic advances is harder than ever. But take heart! The QuadShot is freshly brewed in your inbox four mornings each week so you can quickly down and digest the day's most pertinent cancer news.
And nothing else will be tolerated, as made clear by the aptly named private equity behemoths in dermatology who wielded their power to force retraction of an unflattering article in the field’s top journal. | Hafner, New York Times 2018